Nestle

Last updated January 31, 2026

125

Innovation Areas

3,230

Inventors

Collaborations

Dibenzopyran and benzocoumarin ampk activators: NestleRecent Research Landscape

Metabolic decline and cellular aging increase systemic disease risk, which is mitigated by engineering specific resorcylic acid scaffolds to modulate AMPK and SGLT2 pathways. Precise chemical substitution on the resorcinol ring allows for targeted enzymatic inhibition to restore glucose homeostasis.

What technical problems is Nestle addressing in Dibenzopyran and benzocoumarin ampk activators?

Insufficient intracellular metabolic precursors

(9)evidences

Insufficient ATP production and metabolic decline at the cellular level. Restoring bioenergetic capacity prevents systemic physiological degradation.

Exercise induced muscle fatigue

(7)evidences

Insufficient cellular energy production and protein synthesis in muscle tissue. Restoring metabolic efficiency prevents physical frailty and sarcopenia.

Insufficient cellular energy homeostasis

(2)evidences

Impaired cellular energy regulation and systemic metabolic decline. Restoring metabolic signaling prevents age-related physiological deterioration.